Double blind placebo controlled trial of nebulised budesonide for croup.

Machine translation Machine translation
类别 Primary study
期刊Archives of disease in childhood
Year 1997
連結 Pubmed, DOI, PubMed Central
目的：要确定是否布地奈德雾化改善症状或缩短的承认与临床诊断的哮吼医院儿童停留期限。方法：采用前瞻性，随机，双盲安慰剂对照试验。患者接受雾化布地奈德或安慰剂，每12小时。主要结果测量住院逗留的时间和臀部30分钟，一，二，四，12，和24小时的分数。结果：87例（89入学）年龄7-116个月进入试。布地奈德雾化是与一个症状在12小时（95％可信区间（CI）的1至3）和24小时（95％CI为0到3）显着改善。以超过3初始臀部评分患者表现在两个小时（95％CI为1至3）症状明显改善。布地奈德雾化也与在住院天数降低33％（95％CI为2％至63％）时，年龄的混杂变量，初始哮吼评分，coryzal症状考虑。结论：布地奈德雾化是一种承认与临床诊断的哮吼医院儿童有效的治疗。
This translation has been produced by an automated software. If you wish to submit your own translation, please send it to translations@epistemonikos.org
Epistemonikos ID: d26cee2ead4cdc75b2b24f85286d941bf95338dd
First added on: Jun 08, 2011
Warning
This is a machine translation from an article in Epistemonikos.

Machine translations cannot be considered reliable in order to make health decisions.

See an official translation in the following languages: English

If you prefer to see the machine translation we assume you accept our terms of use